Stat5a/b in Prostate Cancer Metastasis

被引：3
|
作者：
Gao, Allen C. [1 ]
Zhu, Yezi [1 ]
机构：
[1] Univ Calif Davis, Ctr Comprehens Canc, Dept Urol, Sacramento, CA 95817 USA
来源：
AMERICAN JOURNAL OF PATHOLOGY | 2015年 / 185卷 / 09期
关键词：
MESENCHYMAL TRANSITION; ANDROGEN DEPRIVATION; STEM-CELLS; CASTRATION; RESISTANCE; EMT;
D O I：
10.1016/j.ajpath.2015.06.002
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：2351 / 2353
页数：3
相关论文
共 50 条
  • [1] Targeting transcription factor Stat5a/b as a therapeutic strategy for prostate cancer
    Liao, Zhiyong
    Nevalainen, Marja T.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2011, 3 (02): : 133 - 138
  • [2] Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer
    Liao, Zhiyong
    Lutz, Jacqueline
    Nevalainen, Marja T.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (02): : 186 - 192
  • [3] STAT5A/B Gene Locus Undergoes Amplification during Human Prostate Cancer Progression
    Haddad, Bassem R.
    Gu, Lei
    Mirtti, Tuomas
    Dagvadorj, Ayush
    Vogiatzi, Paraskevi
    Hoang, David T.
    Bajaj, Renu
    Leiby, Benjamin
    Ellsworth, Elyse
    Blackmon, Shauna
    Ruiz, Christian
    Curtis, Mark
    Fortina, Paolo
    Ertel, Adam
    Liu, Chengbao
    Rui, Hallgeir
    Visakorpi, Tapio
    Bubendorf, Lukas
    Lallas, Costas D.
    Trabulsi, Edouard J.
    McCue, Peter
    Gomella, Leonard
    Nevalainen, Marja T.
    AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (06): : 2264 - 2275
  • [4] Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer
    Hoang, David T.
    Gu, Lei
    Liao, Zhiyong
    Shen, Feng
    Talati, Pooja G.
    Koptyra, Mateusz
    Tan, Shyh-Han
    Ellsworth, Elyse
    Gupta, Shilpa
    Montie, Heather
    Dagvadorj, Ayush
    Savolainen, Saija
    Leiby, Benjamin
    Mirtti, Tuomas
    Merry, Diane E.
    Nevalainen, Marja T.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (03) : 713 - 726
  • [5] Computational methods for developing novel small molecule Stat5a/b inhibitors for prostate cancer therapy
    Gianti, Eleonora
    Zauhar, Randy J.
    Nevalainen, Marja
    Njar, Vincent C. O.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [6] Transcription factors Stat5a and Stat5b: Favorable prognostic markers in breast cancer
    Witkiewicz, A.
    Ryder, A.
    Neilson, L. M.
    Utama, F. E.
    Tran, T. H.
    Hyslop, T.
    Rui, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] STAT3 and STAT5a Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer
    Mohanty, S. K.
    Yagiz, K.
    Cinar, B.
    Amin, M. B.
    Luthringer, D.
    Alkan, S.
    LABORATORY INVESTIGATION, 2013, 93 : 444A - 444A
  • [8] STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer
    Mohanty, Sambit K.
    Yagiz, Kader
    Pradhan, Dinesh
    Luthringer, Daniel J.
    Amin, Mahul B.
    Alkan, Serhan
    Cinar, Bekir
    ONCOTARGET, 2017, 8 (49) : 85997 - 86010
  • [9] STAT3 and STAT5a Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer
    Mohanty, S. K.
    Yagiz, K.
    Cinar, B.
    Amin, M. B.
    Luthringer, D.
    Alkan, S.
    MODERN PATHOLOGY, 2013, 26 : 444A - 444A
  • [10] STAT3 and STAT5a are potential therapeutic targets in castration-resistant prostate cancer
    Mohanty, Sambit K.
    Yagiz, Kader
    Luthringer, Luthringer
    Amin, Mahul B.
    Alkan, Serhan
    Cinar, Bekir
    CANCER RESEARCH, 2017, 77
12345